Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04494178Not ApplicableTerminated

G-PUR® for Reduced Dietary Fumonisin Bioavailability

Role: lead

NCT04417647Not ApplicableCompleted

G-Wound (VZ for Wound Treatment)

Role: lead

NCT04138186Not ApplicableUnknown

G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea

Role: lead

NCT04138693Not ApplicableCompleted

G-PUR® for Reduced Lead Bioavailability

Role: lead

NCT03090542Not ApplicableCompleted

GPur- Luminating Oral Cholesterol Kinetics Pilot Study

Role: collaborator

All 5 trials loaded